Galleri Test

This #NationalLifeInsuranceDay we’re sharing Rich’s story as a reminder of the vital role of life insurance in your health management. Rich always emphasized his health, attending annual check-ups and receiving recommended cancer screenings. So when he learned Galleri was offered as a benefit from his life insurance policy, he agreed to take the test. His test came back with a “Cancer Signal Detected” result with a predicted “Cancer Signal Origin” for the head and neck. Further testing confirmed a cancer diagnosis. Watch Rich’s story. #LifeInsurance #CancerScreening See Important Safety Information: http://bit.ly/33m8pFa Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. Based on a clinical study of people ages 50 to 79, around 1% are expected to receive a “Cancer Signal Detected” result. After diagnostic evaluation, around 40% of these people are expected to have a confirmed cancer diagnosis. The overall sensitivity in study participants with head and neck cancer was 85.7% (63.2% for stage I, 82.4% for stage II, 84.2% stage III, 96.0% stage IV).

Every day, our nation’s firefighters put their lives on the line, confronting occupational hazards both seen and unseen. It was an honor to be back at FDIC International this year to share the benefits of multi-cancer early detection testing with some of those brave individuals. Thank you for your service and dedication to the communities you protect. Learn more about adding the Galleri test to your recommended screenings: https://www.galleri.com See Important Safety Information: http://bit.ly/33m8pFa #FDIC2024 #MultiCancerEarlyDetection #Galleri

Save the date for our upcoming webinar hosted by Dr. Adrienne Perkins of GRAIL, to discover how adding multi-cancer early detection testing presents a promising solution to help close the gap when added to recommended cancer screening tests. Register and join us: https://lnkd.in/eJp6tFhT See Important Safety Information: http://bit.ly/33m8pFa The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri should be used in addition to healthcare provider recommended screening tests. #MultiCancerEarlyDetection #CancerScreening

In 2024, an estimated 2,001,140 new cancer cases and 611,720 cancer deaths will occur in the United States.¹ Learn how adding the Galleri test can help you go further with cancer screening by looking for a signal shared by 50+ types of cancer with a single blood draw² at: Galleri.com #CancerScreening #MultiCancerEarlyDetectionTest Important Safety Information: http://bit.ly/33m8pFa The Galleri test should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. References: 1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024 Jan 17. doi: 10.3322/caac.21820. 2. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167-77. DOI: https://lnkd.in/gbV7jCw5.

Did you know that April is Esophageal Cancer Month? This rare but aggressive form of cancer is known for its rapid progression. Review key facts below and learn how incorporating the Galleri test into your recommended screenings can help push the boundaries of what’s possible in cancer screening at Galleri.com. #EsophagealCancerMonth #EsophagealCancer #CancerScreening #MultiCancerEarlyDetectionTest Important Safety Information: http://bit.ly/33m8pFa The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. Based on a clinical study of people ages 50 to 79, around 1% are expected to receive a cancer signal detected result. After diagnostic evaluation, around 40% of these people are expected to have a confirmed cancer diagnosis. The overall sensitivity in study participants with esophagus cancer was 85.0% (12.5% for stage I, 64.7% stage II, 94.7% stage III, 100% stage IV). Reference: 1. Statistics for esophageal cancer | Esophageal cancer Stats. American Cancer Society. https://lnkd.in/eKcUEaRB statistics.html. Accessed 22 Jan. 2024.

We’re ready to connect with you at The Conference Board 2024 Employee Health Care Conference! Make sure to visit our booth! We're happy to answer questions about our session with Dr. Megan Hall, Michele Scott, and Dr. Setu Vora to explore how cancer disproportionately impacts minority employees and what forward-thinking employers can do to help improve access to screening. #EmployeeHealth #EmployeeBenefits #Healthcare #MultiCancerEarlyDetection

April is Cancer Prevention and Early Detection Month! Routine screenings can mean better outcomes for your health—that means more treatment options, more healthy days ahead and more time with the people you love. Learn more: https://bit.ly/3VFUuG6

We’re headed to NYC for The Conference Board 2024 Employee Health Care Conference! Meet us there to hear GRAIL’s Dr. Megan Hall, and Mashantucket Pequot Tribal Nation’s Tribal Councilor, Michele Scott, and Chief Medical Officer, Dr. Setu Vora, discuss adding multi-cancer early detection screening to your employee health benefits package. See Important Safety Information: http://bit.ly/33m8pFa  #EmployeeHealth #EmployeeBenefits #Healthcare #MultiCancerEarlyDetection

Thanks to the Galleri test, Dave was able to discover and proactively treat a rare, chronic blood cancer. “I’m certainly lucky and thankful that I’d had the Galleri test so I could start treating it before I even knew it was affecting my lifestyle...I want to be proactive with my illness.” Watch to see more of Dave’s story. Learn more and see Important Safety Information at Galleri.com. #Galleri #CancerScreening #MultiCancerEarlyDetectionTest The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. The Galleri test should be used in addition to healthcare provider recommended screening tests. Based on a clinical study of people ages 50 to 79, around 1% are expected to receive a cancer signal detected result. After diagnostic evaluation, around 40% of these people are expected to have a confirmed cancer diagnosis. The overall sensitivity in study participants with lymphoma cancer was 56% (27.3% for stage I, 58.3% for stage II, 71.7% stage III, 60.9% stage IV).

#PriMedSouthwest never disappoints. Thank you to everyone who stopped by our booth and came to our sessions to discover the benefits of multi-cancer early detection. Learn how to implement the Galleri test in your practice: https://bit.ly/4aQEfKS #PrimaryCare #MultiCancerEarlyDetection #MCED The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri should be used in addition to healthcare provider recommended screening tests. See Important Safety Information: http://bit.ly/33m8pFa